IT HAS BEEN reported (Stjernsward et al., 1972 ) that radiation for mammary carcinoma lowers the circulating level of thymus (T) lymphocytes for at least 1 year, and these workers suggest that the observed increase in metastases might be related to the lymphopaenia. Other studies (Renoux and Renoux, 1972) have indicated that levamisole inhibits the growth and subsequent lung metastases of Lewis lung (3LL) tumour in C57B1 mice. Using the Lewis lung (3LL) tumour in BDF1 mice, we have modified a model system described by James and Salsbury (1974) to study the anti-tumour and anti-metastatic activity of new compounds including potential anti-helminthic agents chemically related to levamisole (Bell and Wei, 1976) . The most effective of these was found to be 3-(p-chlorophenyl)-2,3 -dihydro -3 -hydroxythiazolo [3,2 -a] -benzimidazole-2-acetic acid (Wy-13,876, NSC 208828) . N s"--CH,CO,H -N-OH 876 Cl MATERIALS AND METHODS Six to 8-week-old male BDF1 mice weighing 19-21 g were used for the tumour studies. This strain is used to conform with Protocol 1.400 of the Drug Research and Development Division of Cancer Treatment, National Cancer Institute. Growth of the Lewis lung carcinoma in the F1 generation of this hybrid is completely comparable with that obtained in the syngeneic C57B1 mouse. The latter line was always employed for stock tumour growth (Geran et al., 1972) . Subcutaneous trochar implants of 2-4mm fragments of 3LL tumour were made in the axillary region. Starting 24 h later the mice received daily intraperitoneal injections of Wy-13,876, or levamisole (kindly supplied by Janssen Laboratories, Belgium), suspended in a solution composed of 1 part of 0-5 00 carboxymethylcellulose (CMC, Methocel, Dow Chemical Company, Midland, Mich.) and 2 parts of physiological saline, while the control animals received only the CMC-physiological saline solution. At the end of the experimental period the mice were killed, the tumour and lungs excised, the primary tumours uAeighed for the determination of T/C ratios (mean tumour weight for treated divided by mean tumour weight for control animals x 100) and the lungs examined for metastases, either by observation of the total lung surface with a dissecting microscope or by histopathological examination. The histopathological examination involved making serial transverse sections of the lungs at intervals of several millimetres until the entire lung mass was used. Twelve to 14 sections were obtained per lung. A haernatoxylin and eosin stain was used and the slides wNere examined microscopically at both low and high magnification so as to identify all metastases, including early ones. All slides were coded before examination by the pathologist to create a blind study.
In order to test the importance of viable circulating lymphocytes for the antitumour activity of Wy-13,876 and levamisole, antithymocyte serum (ATS, Microbiological Associates, Rockville, Md) was administered undiluted by the intraperitoneal route to separate groups of mice implanted with Lewis lung (3LL) tumour at doses of 0-1 ml/mouse one day before tumour implantation and 1 and 5 days after implantation for the first wNeek then twice a week for the remainder of the experiment. Positive control groups that were given cyclophosphamide (Cytoxan, Mead Johnson Laboratories, Evansville, Ind.) as wN-ell as control groups that did not receive any compound, with and without the injection of ATS, were also included in this experiment.
Treatment was stopped on Day 14 and the animals were kept for 4 additional days before killing. The primary tumours erere weighed and the lungs were preserved in formalin and subjected to examination under a dissecting microscope for the determination of the number of lung metastases.
To study the effect of Wy-13,876 or levamisole on T lymphocyte formlation, male CDW rats in groups of 4 were given various doses of the drugs suspended in wvater by gavage, the control rats receiving only water. The rats were fasted overnight, and 18 h after drug administration, blood samples were taken by cardiac puncture using heparinized vacutainers (Becton Dickinson and Co., Rutherford, N.J. Boyum (1968) . The lymphocytes were then washed twAice with HMBSS.
The incubation system for rosette formation, patterned after the procedure of Siegel and Sherman (1972) , consists of 0 1 ml of lymphocyte suspension (1-6 x 106 cells/ ml), 0*1 ml of guinea-pig red blood cells (6-4 x 106 cells/ml) and 0 1 ml of foetal calf serum in HMBSS. The tubes, set up in triplicate for control and experimental groups, are incubated in a shaker bath for 60 min at 370C, the number of rosettes per 100 thymocytes from each of the 3 tubes counted under the microscope, and the results expressed as the mean value of rosettes (T lymphocytes) for the experimental group, divided by the mean value for the control group.
A series of experiments -x'as also conducted wiith mice using the described Lewis lung system in wNhich combination of Wy-13,876 wAith low, anti-tumour doses of cyclophosphamide and 5-fluorouracil (Roche Laboratories, Nutley, N.J.) were used.
Cytotoxicity of Wy-13,876 was determined using HEp-2 human epidermal tumour growi-n as monolayers in tissue culture flasks in a basal serum medium according to the established procedure of Geran et al. (1972) . Various concentrations of Wy-13,876 were prepared in demineralized water and added to the culture tubes, which wNere then incubated at 370C until at least a six-fold increase in total protein was obtained in the control tubes, as indicated by the Lowry assay. Compounds are considered active in this test if they show, an ED50 of < 4 ,tg/ml as an average of 2 assays.
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Daily intraperitoneal injections of different doses of Wy-13,876 were given to separate groups of 10 BDF1 mice for 10 consecutive days to determine the in vivo toxicity of the compound according to the procedure of Reed and Muench (1938) .
RESULTS
Wy-13,876 was not inhibitory to HEp-2 (human epidermal tumour) in vitro below 198 ,ug/ml, indicating that the compound is not cytotoxic. Tests to determine in vivo toxicity of Wy-13,876 (Table I) (Table II) show some inhibition of primary tumour growth by 876. Table IV . Primary tumour weight reduction was seen at both the 100 and 150 mg/kg doses, although only the 150 mg/kg dose brought the T/C value below the 420% level. The histopathological study of the lungs from these mice indicated that at the 150 mg/kg dose, 6 of 10 mice showed no metastases whereas the lungs of the remaining 4 mice showed 1, or 3 to 5 indications of small metastases. At the 100 mg/kg dose, 2 mice showed no metastases; 4 mice, 3-5 tiniy metastases; 2 mice, 6-9 metastases and the final 2, 10-21 metastases. The cyclophosphamide control showed no lung metastases and the negative controls showed a spectrum of metastatic involvement. In comparison with the lungs from the CMC control mice 800 metastases were observed in the lungs of the mice dosed with 150 mg/kg of Wy-13,876 and 52% in the lungs of those given 100 mg/kg. 4-3±0-6 t AMean tumour weight in treated/mean tumour weight for control mice x 100.
I Standard error. § One "Ino take " eliminated from calculation.
In bold type: T/C ratio 42 %, i.e. active dose of compound. (Geran et al., 1972) ATS-treated and untreated group of mice is much greater and the number of lung metastases in the control groups is very much higher. The rosette test, which indicates the capacity to stimulate the generation of T lymphocytes, shows that both Wy-13,876 and levamisole increase T lymphocyte levels in rats. This experiment further suggests that increased T lymphocyte levels may be involved in the anti-metastatic mechanism.
The final experiments concern a study of the capacity of Wy-13,876 to potentiate the anti-tumour activity of 5-fluorouracil and cyclophosphamide and the effect of levamisole on 5-fluorouracil activity.
Chirigos, Pearson and Pryor (1973) have reported on the value of combining chemotherapy and immunostimulation in a murine leukaemia and they have shown that, when levamisole is combined with low doses of 1,3 bis(2-chloroethyl)-1-nitrosourea, a higher percentage of longterm survivors is found. In our experiments a low dose of 5-fluorouracil had at least an additive anti-tumour effect with Wy-13,876, as indicated by the T/C ratios, but it did not affect the activity of levamisole. Low doses of cyclophosphamide also appeared to augment the anti-tumour activity of Wy-13,876 by this criterion.
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